Bacterial Cyclodipeptides Inhibit Invasiveness and Metastasis Progression in the Triple-Negative Breast Cancer MDA-MB-231 Mouse Model
Authors:
- Mayra Xochitl Durán-MaldonadoMDMayra Xochitl Durán-Maldonado
- Marlene Estefania Campos-MoralesMCMarlene Estefania Campos-Morales
- Lorena Martínez-AlcantarLMLorena Martínez-Alcantar
- Laura Hernández-PadillaLHLaura Hernández-Padilla
- Jesús Campos-GarcíaJesús Campos-García
- Ximena Hernandez-RamosXHXimena Hernandez-Ramos
Preprint
- 19 January 2026
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Background: Triple-negative breast cancer (TNBC) is an aggressive subtype associated with a high metastatic rate and low survival worldwide. Bacterial cyclodipeptides (CDPs) exhibit anticancer properties by targeting multiple signaling pathways. Methods: The effect of CDPs on the metastasis of the TNBC MDA-MB-231 cell line was evaluated both in vitro and in advanced-stage tumors in immunosuppressed female mice. Results: CDPs more effectively reduced the migratory and invasive abilities of the MDA-MB-231 cell line than methotrexate (MTX). The anti-metastatic effect correlated with inhibition of the Akt/mTOR/S6K pathway, evidenced by decreased expression of markers such as Gab1, Vimentin, and FOXO1. Mice with MDA-MB-231 xenografts treated with CDPs, alone or in combination with MTX, showed near-complete suppression of primary tumor growth and metastatic foci in tumor and organ tissues. Key proteins involved in signaling pathways associated with tumor progression and metastasis such as p-Akt, p-Gab1, and FOXO1 were markedly reduced expression in tumor tissues following xenografted mice CDPs treated. Notably, genes involved in EMT, invasiveness, and metastasis—including PTEN, SNAIL, CXCL1, BRCA1, GADD45A, and PD-L1—were dysregulated in the livers of animals with TNBC, but CDPs treatment restored them to healthy levels more effectively than MTX. Conclusions: The anti-metastatic effects of CDPs in the MDA-MB-231 line involve inhibiting phosphorylation of components of the Akt/mTOR/S6K pathway and reducing metastasis markers and proliferation regulators, as demonstrated in cultures of the MDA-MB-231 line and in tumor and liver tissues from the TNBC xenograft mouse model. The anti-metastatic activity of CDPs was more effective than MTX alone; however, combined treatment produced a synergistic effect, increasing efficacy. These findings offer new insights into the mechanism of action of CDPs and their potential as candidates for further preclinical development.Keywords
All Related Versions
This publication has 21 references indexed in Scilit:
- Cyclic peptides as an inhibitor of metastasis in breast cancer targeting MMP-1: Computational approachInformatics in Medicine Unlocked, 2022
- Pathogenesis of Triple-Negative Breast CancerAnnual Review of Pathology: Mechanisms of Disease, 2022
- Antiproliferative effect of bacterial cyclodipeptides in the HeLa line of human cervical cancer reveals multiple protein kinase targeting, including mTORC1/C2 complex inhibition in a TSC1/2-dependent mannerApoptosis, 2020
- FOXO transcription factor family in cancer and metastasisCancer and Metastasis Reviews, 2020
- AMPK and AKT protein kinases hierarchically phosphorylate the N-terminus of the FOXO1 transcription factor, modulating interactions with 14-3-3 proteinsJournal of Biological Chemistry, 2019
- Breast Cancer Spheroids Reveal a Differential Cancer Stem Cell Response to Chemotherapeutic TreatmentScientific Reports, 2017
- Non-ribosomal Peptide Synthases from Pseudomonas aeruginosa Play a Role in Cyclodipeptide Biosynthesis, Quorum-Sensing Regulation, and Root Development in a Plant HostMicrobial Ecology, 2016
- Beyond the Diketopiperazine Family with Alternatively Bridged Brevianamide F AnaloguesThe Journal of Organic Chemistry, 2015
- Prognostic value of neutrophil‐to‐lymphocyte ratio in breast cancerFEBS Open Bio, 2015
- Transkingdom signaling based on bacterial cyclodipeptides with auxin activity in plantsProceedings of the National Academy of Sciences, 2011